PATENT CLAIM ANALYSIS

Application Number: 15744507
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
A novel domain of Aggrus involved in the binding to CLEC-2 was searched for, and monoclonal antibodies recognizing the domain were obtained. The newly found PLAG4 domain is important for Aggrus binding to CLEC-2. Monoclonal antibodies recognizing this region were further developed. The present invention can provide novel Aggrus-CLEC-2 binding inhibitors, platelet aggregation inhibitors, cancer metastasis inhibitors, and tumor growth inhibitors using these antibodies.

Claim (Index 1):
A monoclonal antibody binding to a region of Aggrus consisting of a sequence of at least 5 residues of the amino acid sequence represented by SEQ ID NO: 1 (GIRIEDLPT), or a fragment consisting of a functional fragment thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.53191
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14006498', '14914704', '11912757', '13721547', '13095098']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7598823543901405
- 35 USC 102 Novelty (BERT): 0.5533461064442948
- Combined Prediction Score: 0.739228729595556
- Mean Citation Score: 324.1048380000001
- Max Citation Score: 414.65854
- Similarity Product: 319.0639851112485

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test